Institute for Health Metrics and Evaluation (IHME)

• Vision
• Director's Statement
• Governance
  • Board
  • Scientific Oversight Group
• History
• Team

• Who we are
  • Vision
  • Director's Statement
  • Governance
  • History
  • Team
• What we do
  • Research
  • Education and Training
• What you can do
  • Seminars
  • Opportunities
• Information Resources
  • News
  • Publications
  • Datasets

Anne Mills

Anne Mills is Professor of Health Economics and Policy at the London School of Hygiene and Tropical Medicine and Head of the Department of Public Health and Policy.

She has over 30 years’ experience of the health systems of low and middle income countries, and has researched and published widely in the fields of health economics and health systems. Her most recent research interests have been in the organisation and financing of health systems including evaluation of contractual relationships between public and private sectors, and in economic analysis of disease control activities and the appropriate roles of public and private sectors, especially for scaling up malaria control efforts. She has had extensive involvement in supporting capacity development in health economics in low and middle income countries, for example through supporting the health economics research funding activities of the WHO Tropical Disease Research Programme, and Chairing the Board of the Alliance for Health Policy and Systems Research.

She founded, and is Director of, the Health Economics and Financing Programme, which together with its many research partners, has an extensive programme of research focused on increasing knowledge of how best to improve health systems in low and middle income countries. She has advised multilateral, bilateral and government agencies on numerous occasions; acted as specialist advisor to the House of Commons Select Committee on Science and Technology’s enquiry into the use of science in UK international development policy; was a member of WHO’s Commission on Macro-economics and Health and co-chair of its working group 'Improving the health outcomes of the poor'; wrote the communicable disease paper for the first Copenhagen Consensus; and was a member of the US Institute of Medicine (IOM) committee on the economics of anti-malarial drugs. In 2006 she was awarded a CBE for services to medicine and elected Foreign Associate of the IOM.